Australia markets closed

HTG Molecular Diagnostics Inc (65H.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.24200.0000 (0.00%)
As of 04:28PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
6,214
6,366
8,907
8,549
19,204
Cost of revenue
4,867
4,572
4,095
3,992
8,911
Gross profit
1,348
1,794
4,812
4,557
10,293
Operating expenses
Research development
6,474
6,782
6,089
6,080
10,570
Selling general and administrative
14,462
15,842
16,547
18,063
18,682
Total operating expenses
20,936
22,624
22,636
24,143
29,253
Operating income or loss
-19,588
-20,830
-17,824
-19,586
-18,960
Interest expense
745.818
856.731
1,065
1,025
957.535
Total other income/expenses net
-
8.333
1,736
-500.126
-
Income before tax
-20,139
-21,584
-17,123
-20,856
-19,294
Income tax expense
12.669
10.837
22.475
14.415
3.379
Income from continuing operations
-20,152
-21,594
-17,145
-20,870
-19,298
Net income
-20,152
-21,594
-17,145
-20,870
-19,298
Net income available to common shareholders
-20,152
-21,594
-17,145
-20,870
-19,298
Basic EPS
-16.83
-24.28
-29.64
-54.12
-91.20
Diluted EPS
-16.83
-24.28
-29.64
-54.12
-91.20
Basic average shares
1,276
889.284
578.01
385.659
211.664
Diluted average shares
1,276
889.284
578.01
385.659
211.664